MDT

100.26

+3%↑

A

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

MDT

100.26

+3%↑

A

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

MDT

100.26

+3%↑

A

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

MDT

100.26

+3%↑

A

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

MDT

100.26

+3%↑

A

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

Search

Pulse Biosciences Inc

Abrir

SetorSaúde

14.7 2.51

Visão Geral

Variação de preço das ações

24h

Atual

Mín

14.48

Máximo

14.94

Indicadores-chave

By Trading Economics

Rendimento

-217K

-19M

Vendas

86K

86K

EPS

-0.29

Margem de lucro

-22,540.698

Funcionários

75

EBITDA

-228K

-19M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+64.3% upside

Dividendos

By Dow Jones

Próximos Ganhos

26 de mar. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-179M

958M

Abertura anterior

12.19

Fecho anterior

14.7

Sentimento de Notícias

By Acuity

50%

50%

166 / 374 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Very Strong Bearish Evidence

Pulse Biosciences Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

5 de jan. de 2026, 18:06 UTC

Grandes Movimentos do Mercado

LifeMD Shares Rise After Company Offers Novo Nordisk's Wegovy

5 de jan. de 2026, 23:51 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

5 de jan. de 2026, 23:51 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

5 de jan. de 2026, 23:51 UTC

Conversa de Mercado

Nikkei May Rise After Gains on Wall Street -- Market Talk

5 de jan. de 2026, 23:42 UTC

Conversa de Mercado
Notícias Principais

Gold Edges Lower on Likely Technical Correction -- Market Talk

5 de jan. de 2026, 21:52 UTC

Notícias Principais

Oil Stocks, Banks Push Dow to New Record -- WSJ

5 de jan. de 2026, 21:51 UTC

Notícias Principais

Palantir Stock Jumps. How It Benefited from the Venezuela Raid. -- Barrons.com

5 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

5 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

5 de jan. de 2026, 21:38 UTC

Notícias Principais

Stock Market Today: Dow Jumps to Record After U.S. Captures Venezuela's Maduro -- WSJ

5 de jan. de 2026, 21:09 UTC

Aquisições, Fusões, Aquisições de Empresas

SGH, Steel Dynamics Won't Need to Raise Equity to Fund Transaction

5 de jan. de 2026, 21:09 UTC

Aquisições, Fusões, Aquisições de Empresas

SGH, Steel Dynamics to Fund Transaction With Cash, Available Debt Financing

5 de jan. de 2026, 21:08 UTC

Aquisições, Fusões, Aquisições de Empresas

SGH Proposes Minimum One Board Position for BlueScope Directors to Maintain Continuity

5 de jan. de 2026, 21:06 UTC

Aquisições, Fusões, Aquisições de Empresas

SGH, Steel Dynamics Offer Values BlueScope's Equity at A$13.2 Billion

5 de jan. de 2026, 21:06 UTC

Aquisições, Fusões, Aquisições de Empresas

SGH Would Retain Remainder of BlueScope's Operations if Deal Completes

5 de jan. de 2026, 21:05 UTC

Aquisições, Fusões, Aquisições de Empresas

SGH Would Sell BlueScope's North American Operations to Steel Dynamics if Deal Completes

5 de jan. de 2026, 21:05 UTC

Aquisições, Fusões, Aquisições de Empresas

SGH, Steel Dynamics Offering A$30.00/Share in Cash to Acquire BlueScope

5 de jan. de 2026, 21:04 UTC

Aquisições, Fusões, Aquisições de Empresas

SGH, Steel Dynamics Make Takeover Offer for BlueScope Steel

5 de jan. de 2026, 20:18 UTC

Conversa de Mercado

U.S. Natural Gas Extends Losses on Milder Weather Outlook -- Market Talk

5 de jan. de 2026, 20:08 UTC

Conversa de Mercado

Venezuela Needs Billions in Investment for Oil-Production Growth -- Market Talk

5 de jan. de 2026, 19:16 UTC

Conversa de Mercado
Notícias Principais

Alberta Says Canada Needs to Expedite Pipeline Projects Following Trump's Venezuela Move -- Market Talk

5 de jan. de 2026, 18:57 UTC

Conversa de Mercado
Notícias Principais

Quick Return of Venezuelan Oil Barrels A Possibility -- Market Talk

5 de jan. de 2026, 18:23 UTC

Conversa de Mercado

Moody's Should See Boost from Strong Debt Issuance Year -- Market Talk

5 de jan. de 2026, 18:08 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

5 de jan. de 2026, 18:08 UTC

Conversa de Mercado

Market Talk Roundup: Latest on U.S. Politics

5 de jan. de 2026, 18:08 UTC

Conversa de Mercado
Notícias Principais

Canadian Heavy Oil Producers at Risk From a Revitalized Venezuela -- Market Talk

5 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

5 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

5 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

5 de jan. de 2026, 17:08 UTC

Ganhos

Strategy Records $17.44 Billion Unrealized Loss in Fourth Quarter -- WSJ

Comparação entre Pares

Variação de preço

Pulse Biosciences Inc Previsão

Preço-alvo

By TipRanks

64.3% parte superior

Previsão para 12 meses

Média 22 USD  64.3%

Máximo 22 USD

Mínimo 22 USD

Com base em 1 analistas de Wall Street que oferecem metas de preço de 12 meses para Pulse Biosciences Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

1 ratings

1

Comprar

0

Manter

0

Vender

Pontuação Técnica

By Trading Central

16.59 / 17.17Suporte e Resistência

Curto Prazo

Very Strong Bearish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Weak Bearish Evidence

Sentimento

By Acuity

166 / 374 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
help-icon Live chat